William Daniel
Vorsitzender bei MALIN CORPORATION PLC
Vermögen: 147 204 $ am 31.05.2024
Profil
William Francis Daniel is currently the Independent Chairman at Malin Corp.
Plc and a Director at Elan Pharma International Ltd.
Previously, he served as an Independent Director at Horizon Therapeutics Plc from 2014 to 2023.
He was also the Financial Director at Xtravision Plc from 1990 to 1992 and the President & Director at the Institute of Directors In Ireland from 2013 to 2015.
Additionally, he held positions as a Director at Alkermes Plc in 2011 and as the Secretary & Executive Vice President at Elan Corp.
Plc from 2007 to 2013.
He was the Head-Finance at An Post Group and served as the President of the Financial Executives Association.
Mr. Daniel completed his undergraduate degree at University College Dublin.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
MALIN CORPORATION PLC
0,13% | 26.02.2024 | 23 789 ( 0,13% ) | 147 204 $ | 31.05.2024 |
Aktive Positionen von William Daniel
Unternehmen | Position | Beginn |
---|---|---|
MALIN CORPORATION PLC | Vorsitzender | 02.08.2019 |
Elan Pharma International Ltd.
Elan Pharma International Ltd. Pharmaceuticals: MajorHealth Technology Part of Perrigo Co. Plc, Elan Pharma International Ltd. develops, manufactures and distributes pharmaceutical products. The company is based in South San Francisco, CA. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von William Daniel
Unternehmen | Position | Ende |
---|---|---|
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Direktor/Vorstandsmitglied | 06.10.2023 |
Institute of Directors In Ireland
Institute of Directors In Ireland Miscellaneous Commercial ServicesCommercial Services Institute of Directors In Ireland promotes governance and develops leadership skills. It offer services to boards in Ireland including a non-executive director and chairperson appointment service through the boardroom centre, a board evaluation service, carried out by highly experienced assessors. The company is headquartered in Dublin, Ireland. | Präsident | 01.05.2015 |
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Direktor/Vorstandsmitglied | 01.01.2007 |
ALKERMES PLC | Direktor/Vorstandsmitglied | 16.09.2011 |
Xtravision Plc | Finanzdirektor/CFO | 01.01.1992 |
Ausbildung von William Daniel
University College Dublin | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
MALIN CORPORATION PLC | Health Technology |
ALKERMES PLC | Health Technology |
Private Unternehmen | 7 |
---|---|
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Health Technology |
Elan Pharma International Ltd.
Elan Pharma International Ltd. Pharmaceuticals: MajorHealth Technology Part of Perrigo Co. Plc, Elan Pharma International Ltd. develops, manufactures and distributes pharmaceutical products. The company is based in South San Francisco, CA. | Health Technology |
Horizon Therapeutics Plc
Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
An Post Group
An Post Group Air Freight/CouriersTransportation An Post Group engages in the provision of postal, communication, retail, and financial services. The firm offers international courier services, passport express, DeliveryBox, state savings and investments, insurance services, e-Docketing, marketing services, and publication services. The company was founded in 1984 and is headquartered in Dublin, Ireland. | Transportation |
Xtravision Plc | Consumer Services |
Institute of Directors In Ireland
Institute of Directors In Ireland Miscellaneous Commercial ServicesCommercial Services Institute of Directors In Ireland promotes governance and develops leadership skills. It offer services to boards in Ireland including a non-executive director and chairperson appointment service through the boardroom centre, a board evaluation service, carried out by highly experienced assessors. The company is headquartered in Dublin, Ireland. | Commercial Services |
Financial Executives Association |